GENERALIZED GANGLIOSIDOSIS
\d͡ʒˈɛnəɹə͡lˌa͡ɪzd ɡˌaŋɡlɪˌɒsɪdˈə͡ʊsɪs], \dʒˈɛnəɹəlˌaɪzd ɡˌaŋɡlɪˌɒsɪdˈəʊsɪs], \dʒ_ˈɛ_n_ə_ɹ_əl_ˌaɪ_z_d ɡ_ˌa_ŋ_ɡ_l_ɪ__ˌɒ_s_ɪ_d_ˈəʊ_s_ɪ_s]\
Sort: Oldest first
-
A form of gangliosidosis characterized by accumulation of G (M1) GANGLIOSIDE and oligosaccharides in lysosomes caused by an absence or severe deficiency of the enzyme BETA-GALACTOSIDASE (type A1). The three phenotypes of this disorder are infantile (generalized), juvenile, and adult. The infantile form is characterized by skeletal abnormalities, hypotonia, poor psychomotor development, hirsutism, hepatosplenomegaly, and facial abnormalities. The juvenile form features hyperacusis, seizures, and psychomotor retardation. The adult form features progressive intellectual deterioration, involuntary movements, ataxia, and spasticity. (From Menkes, Textbook of Child Neurology, 5th ed, pp96-7)
By DataStellar Co., Ltd
Word of the day
Photofrin II
- purified component HEMATOPORPHYRIN DERIVATIVE, consists a mixture oligomeric porphyrins. used therapy (PHOTORADIATION); treat malignant lesions with visible light and experimentally as an antiviral agent. It is the first drug to be approved in use of photodynamic therapy United States.